DAA Treatment in Donor HCV-positive to Recipient HCV-negative Heart Transplant

Stopped Protocol transitioned to standard of care, no funding available to support research work

Conditions

• End Stage Heart Disease
• Hepatitis C

Interventions

• DRUG: Clinically prescribed direct acting antiviral

Sponsor

Massachusetts General Hospital